Evidence map›Paper›PMID 42152612›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2026

Longitudinal multiomic and spatial transcriptomic profiling of lupus nephritis progression in a murine model.

Eduardo Patino-Martinez, Morteza Hajihosseini, Norio Hanata, Kan Jiang, Cihan Oguz, Mayank Tandon, Paul Schaughency, Davide Randazzo, Faiza Naz, Stefania Dell'Orso and 3 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Eduardo Patino-MartinezNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Morteza HajihosseiniSchool of Public Health, University of Alberta, Edmonton, AB, Canada.
Norio HanataNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Kan JiangNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Cihan OguzIntegrated Data Sciences Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States.ORCID 0000-0002-2860-3546
Mayank TandonIntegrated Data Sciences Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States.
Paul SchaughencyIntegrated Data Sciences Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States.ORCID 0000-0002-3358-2102
Davide RandazzoNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Faiza NazNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Stefania Dell'OrsoNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Luz P BlancoNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Saumyadipta PyneNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Mariana J KaplanNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.

Funding

Systemic AutoimmunityZIAAR041199 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI KAPLAN, MARIANA · 2014 to 2025
$32.5M
Intramural NIH HHS ZIA AR041199
6 · The paper itself

Abstract

Lupus nephritis (LN), a severe manifestation of systemic lupus erythematosus, is characterized by progressive renal inflammation and tissue injury. To define molecular mechanisms underlying LN progression, we analyzed temporal and spatial transcriptomic profiles in kidneys of lupus-prone New Zealand Black/White F1 mice at 10, 20, and 30 weeks of age, representing preclinical, early, and advanced disease stages. Bulk RNA sequencing revealed minimal transcriptional changes between 10 and 20 weeks but marked shifts by 30 weeks, coinciding with overt nephritis. Differential expression and pathway analyses demonstrated significant upregulation of genes involved in immune cell recruitment, B-cell activation, cytokine signaling, fibrosis, and oxidative stress. To assess translational relevance, we mapped a curated human LN gene signature to orthologous mouse genes. Most orthologs showed significant temporal correlation with disease progression, indicating cross-species concordance and reinforcing the clinical relevance of the model. Spatial transcriptomics of 30-week kidneys identified 9 spatial clusters with distinct expression profiles, including regions enriched for B cells and myeloid cells. One cluster showed high expression of immunoglobulin genes and lymphocyte recruitment markers. Spatial molecular signature analysis identified inflammatory programs enriched for cytokine/chemokine and interferon pathways. Immunofluorescence confirmed peritubular TNFRSF1A expression, CCR5+ inflammatory cell accumulation, compartmentalized NRF2-HMOX1 responses, and CXCL13-associated tertiary lymphoid structure formation. These findings define stage-specific molecular programs and spatially organized immune niches in LN, providing mechanistic insight and potential targets for early intervention.

Indexed as

KidneyLupus NephritisTranscriptomeAnimalsB-LymphocytesDisease Models, AnimalDisease ProgressionFemaleGene Expression ProfilingHumansMiceMice, Inbred NZBMultiomicsSpatial Transcriptomicsautoimmunitylupus nephritisspatial transcriptomicssystemic lupus erythematosus

Identifiers

PMID42152612
PMCPMC13338671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.